Product Information
CARBINOXAMINE MALEATE 4 MG TAB is a generic product labeled by BioComp Pharma Inc., priced at $0.3981 per EA under NDC 44523082501. Its NADAC has been published 459 times since Sep 28, 2016.
FDA first approved this application on May 27, 2011.
Strength
4 mg/1
Manufacturer
BioComp Pharma Inc.NDC
44523082501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CARBINOXAMINE MALEATEApproval Type
Generic (ANDA)
FDA Application
ANDA090756FDA Approved
5/27/2011
On Market Since
5/27/2011
Pharmacological Classes
Price Statistics
The NADAC for CARBINOXAMINE MALEATE 4 MG TAB has been published 459 times since Sep 28, 2016, and over the history we have for it it has declined 20.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3981 per EA |
|---|---|
| All-time high | $0.5017 (Mar 15, 2017) |
| All-time low | $0.3257 (Oct 23, 2019) |
| 52-week high | $0.4388 |
| 52-week low | $0.3981 |
| Median price | $0.4112 |
| Average price | $0.4084 |
| Largest weekly change | +35.3% (Jan 17, 2024) |
| Weeks tracked | 459 |
| Tracking since | Sep 28, 2016 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
BioComp Pharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Carbinoxamine Maleate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CARBINOXAMINE MALEATE 4 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for CARBINOXAMINE MALEATE 4 MG TAB, manufactured by BioComp Pharma Inc., is $0.3981 per EA (NDC 44523082501), effective Sep 30, 2026.
How has the price of CARBINOXAMINE MALEATE 4 MG TAB changed over time?
Over the history we have for it, the NADAC for CARBINOXAMINE MALEATE 4 MG TAB has declined 20.1%. It has been tracked across 459 weekly CMS publications since Sep 28, 2016.
What are the highest and lowest recorded NADAC prices for CARBINOXAMINE MALEATE 4 MG TAB?
Since Sep 28, 2016, the NADAC for CARBINOXAMINE MALEATE 4 MG TAB has ranged from a low of $0.3257 (Oct 23, 2019) to a high of $0.5017 (Mar 15, 2017), with a median of $0.4112 per EA.
Are there cheaper alternatives to CARBINOXAMINE MALEATE 4 MG TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CARBINOXAMINE MALEATE 4 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures CARBINOXAMINE MALEATE 4 MG TAB?
CARBINOXAMINE MALEATE 4 MG TAB (NDC 44523082501) is labeled by BioComp Pharma Inc., and CMS classifies it as a generic product.